Two years ago, AIDS activism catapulted Yale into the national spotlight. Doctors Without Borders, a Nobel Prize-winning humanitarian group, had asked the University to relax the patent for its famous AIDS drug, d4T, in South Africa, because the prices charged by the drug’s producer, Bristol-Myers Squibb, were too high for African governments. After weeks of
»